TABLE 3.
Enriched biological pathways identified based on 788 genes mapped to the CpGs from the EWAS analysis1
Term | Term description | P value | FDR |
---|---|---|---|
GO:0007399 | nervous system development2 | 6.96E−09 | 1.35E−05 |
GO:0051094 | positive regulation of developmental process | 2.68E−08 | 5.20E−05 |
GO:0030029 | actin filament-based process | 6.83E−08 | 1.33E−04 |
GO:0048699 | generation of neurons2 | 9.96E−08 | 1.93E−04 |
GO:0035295 | tube development | 1.25E−07 | 2.43E−04 |
GO:0045595 | regulation of cell differentiation | 1.26E−07 | 2.45E−04 |
GO:0022008 | neurogenesis2 | 1.38E−07 | 2.69E−04 |
GO:0051240 | positive regulation of multicellular organismal process | 1.59E−07 | 3.08E−04 |
GO:0048468 | cell development | 1.73E−07 | 3.36E−04 |
GO:0030182 | neuron differentiation2 | 2.43E−07 | 4.72E−04 |
GO:0006928 | movement of cell or subcellular component | 2.60E−07 | 5.04E−04 |
GO:0045597 | positive regulation of cell differentiation | 4.70E−07 | 9.11E−04 |
GO:2000026 | regulation of multicellular organismal development | 6.12E−07 | 1.19E−03 |
GO:0009790 | embryo development | 9.80E−07 | 1.90E−03 |
GO:0051128 | regulation of cellular component organization | 2.02E−06 | 3.92E−03 |
GO:0051960 | regulation of nervous system development2 | 2.37E−06 | 4.60E−03 |
GO:0035239 | tube morphogenesis | 2.40E−06 | 4.65E−03 |
GO:0060429 | epithelium development | 2.66E−06 | 5.17E−03 |
GO:0007389 | pattern specification process | 3.26E−06 | 6.33E−03 |
GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 5.06E−06 | 9.82E−03 |
GO:0050767 | regulation of neurogenesis2 | 6.37E−06 | 1.24E−02 |
GO:0006366 | transcription from RNA polymerase II promoter | 8.03E−06 | 1.56E−02 |
GO:0045664 | regulation of neuron differentiation2 | 8.45E−06 | 1.64E−02 |
GO:0052697 | xenobiotic glucuronidation | 9.80E−06 | 1.90E−02 |
GO:0010557 | positive regulation of macromolecule biosynthetic process | 1.07E−05 | 2.08E−02 |
GO:1902680 | positive regulation of RNA biosynthetic process | 1.09E−05 | 2.11E−02 |
GO:0072358 | cardiovascular system development | 1.09E−05 | 2.12E−02 |
GO:0072359 | circulatory system development | 1.09E−05 | 2.12E−02 |
GO:0045893 | positive regulation of transcription, DNA-templated | 1.11E−05 | 2.16E−02 |
GO:1903508 | positive regulation of nucleic acid–templated transcription | 1.11E−05 | 2.16E−02 |
GO:0031328 | positive regulation of cellular biosynthetic process | 1.18E−05 | 2.28E−02 |
GO:0060562 | epithelial tube morphogenesis | 1.19E−05 | 2.30E−02 |
GO:0060284 | regulation of cell development | 1.25E−05 | 2.42E−02 |
GO:0048646 | anatomical structure formation involved in morphogenesis | 1.32E−05 | 2.56E−02 |
GO:0009891 | positive regulation of biosynthetic process | 1.51E−05 | 2.94E−02 |
GO:0021915 | neural tube development2 | 1.69E−05 | 3.28E−02 |
GO:0051130 | positive regulation of cellular component organization | 1.87E−05 | 3.63E−02 |
GO:0006357 | regulation of transcription from RNA polymerase II promoter | 1.92E−05 | 3.73E−02 |
GO:0050769 | positive regulation of neurogenesis2 | 2.24E−05 | 4.34E−02 |
GO:0010628 | positive regulation of gene expression | 2.28E−05 | 4.43E−02 |
Gene set enrichment analysis was conducted based on 788 genes that were mapped to the top differentially methylated CpGs (P < 0.001 in the EWAS analysis). The top identified gene ontology (GO) terms are classes of genes that were overly represented in the 788 genes. The P value and false discovery rate (FDR) of enrichment test for each GO term are presented.
Biological pathways related to nervous system development and its child terms in the GO hierarchy that reached statistical significance (FDR<0.05).